Y-Intercept (HK)’s Legend Biotech LEGN Stock Holding History

Y-Intercept (HK)’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$720K	Sell	24,934 -198,362	-89%	-$5.35M	0.01%	1182
2026 Q1	$4.04M	Buy	+223,296	New	+$4.26M	0.08%	416
2024 Q4	–	Sell	-9,391	Closed	-$458K	–	1446
2024 Q3	$458K	Buy	+9,391	New	+$500K	0.03%	815
2024 Q2	–	Sell	-4,570	Closed	-$256K	–	1669
2024 Q1	$256K	Buy	+4,570	New	+$276K	0.02%	1039
2023 Q3	–	Sell	-5,355	Closed	-$370K	–	1355
2023 Q2	$370K	Buy	+5,355	New	+$350K	0.04%	692

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Y-Intercept (HK)'s LEGN Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Legend Biotech (LEGN) stake by 89% in Q2 2026, selling an estimated $5.35M and leaving 24,934 shares worth $720K. The position accounts for 0.01% of the portfolio, ranked #1182.

Y-Intercept (HK) first reported a position in LEGN in Q2 2023 and has held it in 5 quarters since. The position peaked at $4.04M in Q1 2026. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Y-Intercept (HK) held 24,934 shares of Legend Biotech worth $720K as of Q2 2026.
Y-Intercept (HK) sold 198,362 Legend Biotech shares in Q2 2026, an estimated $5.35M.
Legend Biotech made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1182 holding.
Y-Intercept (HK) first reported a position in Legend Biotech in Q2 2023 and has held it in 5 quarters since.
Y-Intercept (HK)'s Legend Biotech position peaked at $4.04M in Q1 2026.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.